Triazene compounds: mechanism of action and related DNA repair systems.
about
O(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsCharacterization of a novel anti-cancer compound for astrocytomasTemozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 ExpressionTemozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cellsDifferential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsEfficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanomaHistone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Divergent ß-hairpins determine double-strand versus single-strand substrate recognition of human AlkB-homologues 2 and 3Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations.PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanomaOvercoming temozolomide resistance in glioblastoma via dual inhibition of NAD+ biosynthesis and base excision repairPotential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.Molecular and genetic diversity in the metastatic process of melanomaExploring the roles of nucleobase desolvation and shape complementarity during the misreplication of O(6)-methylguanine.Targeting the parasite's DNA with methyltriazenyl purine analogs is a safe, selective, and efficacious antitrypanosomal strategyMismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells.Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell lineSynthesis and characterization of DNA minor groove binding alkylating agentsProfound impairment of adaptive immune responses by alkylating chemotherapyTranscription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymeraseThymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line.Combination of lentivirus-mediated silencing of PPM1D and temozolomide chemotherapy eradicates malignant glioma through cell apoptosis and cell cycle arrest.Impairment of APE1 function enhances cellular sensitivity to clinically relevant alkylators and antimetabolites.1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G2/M phase.Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.Towards tailored therapy of glioblastoma multiforme.Molecular mechanisms of temozolomide resistance in glioblastoma multiforme.Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.Cytochrome P450-activated prodrugs.Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.DNA-Targeted Inhibition of MGMT.Honokiol Inhibits DNA Polymerases β and λ and Increases Bleomycin Sensitivity of Human Cancer Cells.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.On glioblastoma and the search for a cure: where do we stand?Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature.mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells.Synthesis, and In-vitro Cytotoxicity Studies of a Series of Triazene Derivatives on Human Cancer Cell Lines.
P2860
Q26853112-C2E822B6-1026-43FA-9B97-5D18FC1C4058Q28543237-A1E66CAA-24D2-41B0-ACF4-76F8809F068DQ28550138-DB5D11E0-50B2-4AA6-BAE3-EDEAC34D7FA6Q33427688-449B0153-F430-43FE-AF49-9F9E0542C16BQ33588294-E251CB22-4EA9-4D65-9E47-03CE90738915Q33838195-E10451F6-D981-472B-BE7A-E12C0C9B1F46Q33968014-2C71413B-537F-4CE8-B477-9DD3BCBD3139Q34051168-9DC1256C-5438-4B60-895B-CA453997CFD4Q34101036-08F259E4-F93D-4EAF-9950-DFF86C18460DQ34119232-88852099-6D46-4572-BEA5-C7A8FAC56093Q34160516-A884BB0B-5673-48D1-8330-9D5FE560E654Q34667977-8C1AF9E6-FBBD-4EBE-AA32-2977C64C9034Q34802264-8FA10DC2-0AC1-4CF6-9B29-F8B8F42D3F2BQ35016534-587CE8E0-C87A-4448-8E1D-A8ED7F6BD08CQ35177775-5FC60417-FEB2-45DB-BC2A-147E424E5199Q35196506-0C73FE93-8D21-4E16-8325-09F7C7E2690BQ36158447-BE0C7A02-3348-4851-BBE3-C79A3F3B194BQ36387895-AD442C63-F910-4466-A66A-40C2542E2F88Q36681945-7B3E5F5C-54ED-4DA1-9FCD-F56BE24B5481Q36687919-A5C36AEC-C11D-4E64-B31B-198392065B30Q36746192-62784A35-2817-480A-99C8-62699799213DQ36922577-D9154D0D-D89C-4FB9-B8D2-D7CBBF9AEC31Q36972108-BD2FB080-279F-4AFD-A87B-AA3EB8189D82Q37306947-E8B20009-3167-4EED-85D9-CE8D4EA99F21Q37321206-042DA383-8669-4777-8C82-025549B480FFQ37349299-BDEC9C4E-692E-4530-903C-78E6A93BC8C7Q37744772-400860EF-5537-4535-8970-F3EF4B5B75CCQ37865580-BEFA1527-2F34-489E-BB72-5ABE22871AD0Q37908815-EE8FCF7F-3AF1-421E-9632-12B8A8A6AE31Q38010801-25A29A1A-D02E-498A-8145-2483C7405AA0Q38019607-B9267FC2-A3E7-4557-986F-4215E37190C0Q38077550-FF6A1C23-0DBA-4DBD-BE24-3D00AA37C1F6Q38650974-A32B8134-51C5-4671-9053-FB4410C82E96Q38717375-CD1CC5A2-A911-4CEA-B800-179D340CA429Q38722365-9E8B9138-438E-471D-876D-118AFC7FE60EQ38730989-792AF2C4-6C19-4DE0-82AC-8D74D6DBDFECQ38756293-A2CB836D-C4ED-48B2-B6EF-2599BA0DC34EQ38926305-E92FF512-F946-40FD-9C67-799BB06EBA12Q38987085-35837DC8-9AD2-4211-AFB2-A35235880861Q39024309-53E3E3CF-DB5F-4946-8836-749ED5535351
P2860
Triazene compounds: mechanism of action and related DNA repair systems.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Triazene compounds: mechanism of action and related DNA repair systems.
@en
type
label
Triazene compounds: mechanism of action and related DNA repair systems.
@en
prefLabel
Triazene compounds: mechanism of action and related DNA repair systems.
@en
P2093
P1476
Triazene compounds: mechanism of action and related DNA repair systems
@en
P2093
Francesco Marchesi
Francesco Torino
Grazia Tortorelli
Liana De Vecchis
Mario Turriziani
P304
P356
10.1016/J.PHRS.2007.08.003
P577
2007-08-09T00:00:00Z